Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke

Summary

This is a 20-week study consisting of a 12-week multicenter, randomized,double-blind adaptive study to compare efficacy and safety of Qizhitongluo Capsule,Naoxintong Capsule and placebo in the recovery phase of ischemic stroke with qi deficiency and blood stasis syndrome, and a 8-week post-treatment safety follow-up.After 312 patients complete 12 weeks of treatment there will be an interim analysis.

Timeline

Start

2013-10

Primary completion

2016-10

Completion

2016-10

Drugs

Indications